Gerhard Mayr

Gerhard N.
Mayr is currently Director at Project HOPE-The-People-To-People Health Foundation, Inc. since 2002, Director at Vienna Science, Research & Technology Foundation since 2002, Director at Vienna Science & Technology Fund, and Member at Insead Business School since 2000.
Former positions include Non-Executive Director at OMV AG from 2002 to 2009, Non-Executive Director at Alcon AG from 2007 to 2010, Director at Codexis, Inc., Independent Director at Almirall SA, Independent Non-Executive Director at UCB SA from 2005 to 2017, Non-Executive Director at Lonza Group AG from 2010 to 2013, Non-Executive Director at Bank Austria AG, Director at European Federation of Pharmaceutical Industries & Assns from 1995 to 1997 and from 2000 to 2002, Director at U.S.-Egypt Presidents' Council from 1999 to 2004, Director at UniCredit Bank Austria AG from 1998 to 2006, Director at Aragen Life Sciences Ltd. from 2008 to 2024, and Executive Vice President-Pharmaceutical Operations at Eli Lilly & Co. from 1972 to 2004.
Education includes an MBA from Stanford University conferred in 1972 and a graduate degree from Swiss Federal Institute of Technology conferred in 1969.